- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03775343
Early Postoperative Cognitive Impairment in Elderly Patients Following Ocular Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primary aim of this study is to evaluate changes in cognitive function in the early postoperative phase after minor surgery in patients of older age (≥65 years).
Background: Postoperative cognitive dysfunction can be a serious complication after surgery and is associated with higher mortality.Several studies have demonstrated that major surgery and patients of older age are risk factors for the incidence of cognitive decline in the postoperative phase. Only a few studies investigated the early postoperative changes in cognitive function (< 24 hours) after minor, day case surgeries in older patients (≥65 years), demonstrating a higher incidence than observed ≥1 week after surgery.
Aim of the project: This study aimed to investigate changes in cognitive function after minor surgery in an elderly patient cohort.
It is the effort to plan perioperative care that can reduce the incidence of postoperative cognitive dysfunction in elderly.
Hypothesis: The present study support the hypothesis that changes in cognitive function after ocular surgery will be greater in the general anesthesia group compared to the sedoanalgesia group.
Methods:
The study will be conducted as a single center, prospective, observational controlled trial at the Medical University of Vienna, Austria.
This prospective and observational study involves consecutive elderly patients (≥65 years) undergoing a minor surgery using general anesthesia or local anesthesia with sedoanalgesia. Fifty patients, 65 years and older, scheduled for elective minor ocular surgery and 25 participants as control group without surgical intervention will be recruited.
Enrollees will be divided in 3 groups:
25 patients general anaesthesia (GA), 25 patients sedoanalgesia combined with local anaesthesia (SA) and 25 participants as control group(CO) without surgical intervention.
Anesthesia will be induced in a standardized fashion in both groups (GA,SA). At baseline the performance on neurocognitive testing using the Mini Mental State Examination (MMSE) hast to be ≥24, otherwise participants will be excluded.
The design utilizes prospective serial assessments of cognitive status. The participants will be evaluated preoperatively and postoperatively over 3 time-points (preoperatively, 6 and 24 hours after surgery) using the Neurocognitive Test Battery Vienna (NTBV) for cognitive assessment.
At the same time points blood tests for plasma levels of S 100-B, IL-6, CRP, vitamin B 12, vitamin D, homocysteine and folic acid will be taken.
This project will investigate the correlation between perioperative changes in these serum parameters with neurocognitive outcome in the elderly after minor surgery to explore whether the concentrations of these parameters can be used as predictors of postoperative cognitive dysfunction and to provide reference for postoperative cognitive dysfunction prevention, early detection and timely diagnosis and treatment.
Further purpose of this study is to investigate if there is an association between changes in intraoperative cerebral oxygenation, changes in perioperative blood pressure, depth of anaesthesia and the presence of cognitive deterioration after surgery.
It is the effort to plan perioperative care that can reduce the incidence of postoperative changes in cognitive function.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Contact
- Name: Marita Windpassinger, MD
- Phone Number: 41020 +43140400
- Email: marita.windpassinger@meduniwien.ac.at
Study Contact Backup
- Name: Olga Plattner, Prof.
- Phone Number: 41020 +43140400
- Email: olga.plattner@meduniwien.ac.at
Study Locations
-
-
-
Vienna, Austria, 1090
- Medical University Vienna
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
50 patients 65 years and older without any significant mental (MMSE ≥24) or neuropsychiatric disorders scheduled for elective ocular surgery requiring general anaesthesia or sedoanalgesia will be undergoing serial cognitive assessements pre- and postoperatively over 3 time-points.
To determine a normal reference value of cognitive functions, a group of 25 participants in the same age (≥65 years)and without surgical intervention will be recruited as a control group and undergo serial cognitive assessements over 3 time-points.
Description
Inclusion Criteria:
- Patients age 65 and older
- scheduled to undergo elective ocular surgery
- American Society of Anesthesiologists class I, II or III
- MMSE score ≥ 24
- The people signed informed consent.
- Expected surgical duration <90 minutes
- Able to follow study instructions.
Exclusion Criteria:
- Patients age < 65 years
- Emergent nature of the ocular surgery
- American Society of Anesthesiologists class IV
- MMSE score < 24
- unsigned informed consent
- Expected surgical duration >90 minutes
- Not able to follow study instructions.
- History of psychiatric or neurologic disorders (epilepsy, trauma, stroke,depressive disorders, hemorrhage, transient ischemic attack
- Drug or substance abuse history
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
General Anesthesia
General anesthesia: 25 patients older than 65 years, undergoing elective eye surgery under general anesthesia. Intervention: neurocognitive testing (Neurocognitive Test Battery) preoperative, 6 and 24 hours postoperative. Blood sampling before surgery (baseline), immediately postoperative, 6 and 24 hours after surgery. |
neurocognitive testing: preoperative(baseline), 6 and 24 hours postoperative.
Blood sampling before surgery (baseline), immediately postoperative, 6 and 24 hours after surgery, investigating plasma levels of S 100-B, CRP, vitamines, homocysteine and folic acid
|
Local anesthesia with sedoanalgesia
25 patients older than 65 years, undergoing elective eye surgery under local anesthesia in combination with sedoanalgesia. Intervention: neurocognitive testing (Neurocognitive Test Battery) preoperative, 6 and 24 hours postoperative Blood sampling before surgery (baseline), immediately postoperative, 6 and 24 hours after surgery. |
neurocognitive testing: preoperative(baseline), 6 and 24 hours postoperative.
Blood sampling before surgery (baseline), immediately postoperative, 6 and 24 hours after surgery, investigating plasma levels of S 100-B, CRP, vitamines, homocysteine and folic acid
|
Control Group
25 patients, not undergoing any operative intervention. To determine a normal reference value of cognitive functions, a group of 25 individuals without an operative intervention will be recruited as a control group. Intervention: neurocognitive testing (Neurocognitive Test Battery) at 3 determined time points (0, 6 and 24 hours) |
neurocognitive testing: preoperative(baseline), 6 and 24 hours postoperative.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Neuropsychological Test Battery Vienna (NTBV)
Time Frame: before surgery (baseline) and 24 hours after surgery
|
The Neuropsychological Test Battery Vienna (NTBV) ist a cognitive test to assess a broad range of cognitive abilities.(Lehrner
J., 2007) It was created to detect cognitive impairment in Alzheimer's Disease (Lehrner J., 2007).
The investigators will investigate changes in NTBV between baseline compared to 24 hour after minor surgery using regression based z-score analyses (-1,5 - + 1,5 standard deviation(SD) ; > -1,5 SD indicating a larger decline in cognitive function).
|
before surgery (baseline) and 24 hours after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Neuropsychological Test Battery Vienna (NTBV)
Time Frame: before surgery(baseline) and 6 hours after surgery
|
The Neuropsychological Test Battery Vienna (NTBV) ist a cognitive test.
(Lehrner J., 2007)
|
before surgery(baseline) and 6 hours after surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood sampling- S100b levels
Time Frame: before surgery, at the end point of surgery, 6 and 24 hours after surgery
|
Blood sampling will be taken at all patients scheduled for elective ocular surgery.
Levels of S100-B protein (µg/L) will be obtained from venous blood samples collected before surgery, at the end point of surgery, 6 and 24 hours after surgery.
|
before surgery, at the end point of surgery, 6 and 24 hours after surgery
|
Blood sampling- IL-6 levels
Time Frame: before surgery, at the end point of surgery, 6 and 24 hours after surgery
|
Blood sampling will be taken at all patients scheduled for elective ocular surgery.
Serum levels of interleukin-6 type cytokines (IL-6 (pg/mL)) will be obtained from venous blood samples collected before surgery, at the end point of surgery, 6 and 24 hours after surgery.
|
before surgery, at the end point of surgery, 6 and 24 hours after surgery
|
Blood sampling- CRP levels
Time Frame: before surgery, at the end point of surgery, 6 and 24 hours after surgery
|
Blood sampling will be taken at all patients scheduled for elective ocular surgery.
Levels of C-Reactive Protein (CRP) (mg/L)will be obtained from venous blood samples collected before surgery, at the end point of surgery, 6 and 24 hours after surgery.
|
before surgery, at the end point of surgery, 6 and 24 hours after surgery
|
Blood sampling- vitamin B12 levels
Time Frame: before surgery, at the end point of surgery, 6 and 24 hours after surgery
|
Blood sampling will be taken at all patients scheduled for elective ocular surgery.
Levels of vitamin B12 (pg/mL) will be obtained from venous blood samples collected before surgery, at the end point of surgery, 6 and 24 hours after surgery.
|
before surgery, at the end point of surgery, 6 and 24 hours after surgery
|
Blood sampling- vitamin D levels
Time Frame: before surgery, at the end point of surgery, 6 and 24 hours after surgery
|
Blood sampling will be taken at all patients scheduled for elective ocular surgery.
Levels of vitamin D (ng/ml) will be obtained from venous blood samples collected before surgery, at the end point of surgery, 6 and 24 hours after surgery.
|
before surgery, at the end point of surgery, 6 and 24 hours after surgery
|
Blood sampling- homocysteine levels
Time Frame: before surgery, at the end point of surgery, 6 and 24 hours after surgery
|
Blood sampling will be taken at all patients scheduled for elective ocular surgery.
Levels of homocysteine (mcmol/L)will be obtained from venous blood samples collected before surgery, at the end point of surgery, 6 and 24 hours after surgery.
|
before surgery, at the end point of surgery, 6 and 24 hours after surgery
|
Blood sampling- folic acid levels
Time Frame: before surgery, at the end point of surgery, 6 and 24 hours after surgery
|
Blood sampling will be taken at all patients scheduled for elective ocular surgery.
Levels of folic acid (µg/L) will be obtained from venous blood samples collected before surgery, at the end point of surgery, 6 and 24 hours after surgery.
|
before surgery, at the end point of surgery, 6 and 24 hours after surgery
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Lehrner, J.; Maly, J.; Gleiß, A.; Auff, E. & Dal-Bianco, P., Demenzdiagnostik mit Hilfe der Vienna Neuropsychologischen Testbatterie (VNTB): Standardisierung, Normierung und Validierung, Psychol. Österreich, 4, 358-365, 2007.
- Foki T, Hitzl D, Pirker W, Novak K, Pusswald G, Auff E, Lehrner J. Erratum to: Assessment of individual cognitive changes after deep brain stimulation surgery in Parkinson's disease using the Neuropsychological Test Battery Vienna short version. Wien Klin Wochenschr. 2017 Aug;129(15-16):585-587. doi: 10.1007/s00508-017-1210-2. No abstract available.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1907/2017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Decline
-
Jean-François DémonetUniversity of Lausanne HospitalsActive, not recruitingCognitive Performance | Functional Capacity | Subjective Cognitive Decline | Age-related Cognitive DeclineSwitzerland
-
Rotman Research Institute at BaycrestSunnybrook Health Sciences Centre; University of Waterloo; Toronto Rehabilitation... and other collaboratorsTerminatedSubjective Cognitive Decline | Age-Related Cognitive DeclineCanada
-
University of WaterlooUniversity of Ottawa; Baycrest; Université de MontréalRecruiting
-
Vanderbilt University Medical CenterNot yet recruiting
-
Indiana UniversityNational Institute on Aging (NIA)CompletedSubjective Cognitive DeclineUnited States
-
University of PrimorskaCompleted
-
Centre de Recherche de l'Institut Universitaire...Canadian Institutes of Health Research (CIHR); Rotman Research Institute at...Active, not recruitingSubjective Cognitive DeclineCanada
-
University of North Carolina, Chapel HillCompletedMild Cognitive DeclineUnited States
-
BaycrestCompletedSubjective Cognitive DeclineCanada
-
National Taiwan University HospitalNational Taiwan Science Education Center(NTSEC)RecruitingCognitive Training | Subjective Cognitive DeclineTaiwan
Clinical Trials on Neurocognitive Test Battery
-
Jessa HospitalRecruitingPostoperative Cognitive Dysfunction | SurgeryBelgium
-
Vrije Universiteit BrusselResearch Foundation FlandersUnknownChronic Pain | Fibromyalgia | WhiplashBelgium
-
Abramson Cancer Center at Penn MedicineCompleted
-
Seoul National University HospitalRecruitingAutomobile DrivingKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterDr. Susan Love Research Foundation; ENFORMIA INC.Active, not recruitingBreast Cancer SurvivorsUnited States
-
Turku University HospitalEuropean Commission; Ocuspecto OyUnknownGlaucoma | Healthy | Mild Cognitive Impairment | Glaucoma and Mild Cognitive ImpairmentFinland
-
Imperial College Healthcare NHS TrustCompletedHearing Loss, Noise-InducedUnited Kingdom
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Shalvata Mental Health CenterUnknown